EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

In Vitro Diagnostic Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998

This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.

Last updated 11 listopada 2024. Database contains 4821 unique substances/entries.
Filter the list

T-4240 FLUOROCHEMICAL URETHANE DERIVATIVE
413-640-4
-
STOT RE 2
BONJET BLACK 817
418-230-9
163879-69-4
Expl. 1.3; Repr. 2; STOT RE 2; Skin Sens. 1
MONO 442
412-260-6
52658-19-2
Eye Irrit. 2; Skin Sens. 1
INTERMEDIAIRE AR HT 3728
410-065-0
-
Skin Sens. 1
DP 15
410-640-6
-
Skin Irrit. 2; Eye Dam. 1
AMMONIUM DIAS
407-320-3
-
Skin Irrit. 2; Eye Dam. 1
A-88820.605
414-810-0
-
STOT RE 2; Eye Dam. 1
MCP 455
406-240-6
-
Flam. Liq. 3; Skin Corr. 1B
MDI
406-550-1
-
Skin Sens. 1
C.I. DIRECT VIOLET 9; VIOLET PERGASOL EN LIQUIDE
406-910-8
124649-82-7
Acute Tox. 4

Export search results to: